Related Experiment Videos
Acute toxicity of pyrazolones.
The American Journal of Medicine
|November 14, 1983
Summary
Pyrazolone analgesics cause mild poisonings, but severe cases are rare. Hemoperfusion is recommended for severe propyphenazone or aminopyrine intoxication, despite limited data.
Area of Science:
- Toxicology
- Pharmacology
Background:
- Pyrazolone analgesics are common causes of mild poisoning.
- Severe pyrazolone intoxication, though rare, can be life-threatening.
Purpose of the Study:
- To review the clinical features and treatment of severe pyrazolone intoxication.
- To evaluate the potential role of hemoperfusion in managing severe cases.
Main Methods:
- Literature review of severe pyrazolone poisoning cases.
- Analysis of clinical symptoms, toxicity profiles, and treatment options.
- Assessment of hemoperfusion efficacy based on pharmacokinetic data and in vitro trials.
Main Results:
- Aminopyrine and propyphenazone cause severe intoxication with symptoms like coma, convulsions, and shock.
- Liver damage can occur, particularly with phenylbutazone and oxyphenbutazone.
- Hemoperfusion with amberlite XAD-4 resin is suggested as an effective treatment for severe pyrazolone poisoning.
Conclusions:
- Severe pyrazolone intoxication requires prompt supportive care and decontamination.
- Hemoperfusion is a promising therapeutic option for severe cases, warranting further clinical investigation.